Live Earnings Conference Call: Inovio Pharmaceuticals will host a live Q2 2025 earnings call on August 12, 2025 at 4:30PM ET. Follow this link to get details and listen to Inovio Pharmaceuticals' Q2 2025 earnings call when it goes live. Get details. Inovio Pharmaceuticals (INO) Earnings Date, Estimates & Call Transcripts $1.48 +0.04 (+2.43%) As of 03:56 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Inovio Pharmaceuticals Earnings Summary Inovio Pharmaceuticals announced Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.51, which topped the consensus estimate of -$0.74 by $0.23. Quarterly revenue was reported to be $0.07 million, above analysts' expectations of $0.01 million. With a trailing EPS of -$3.19, Inovio Pharmaceuticals' earnings are expected to grow next year, from ($4.23) to ($2.85) per share. Upcoming Q2 Earnings DateAug. 12EstimatedConsensus EPS (May. 13) -$0.74 Actual EPS (May. 13) -$0.51 Beat By $0.23 Actual Revenue (May. 13) $0.07MQ1 2025 Earnings ResourcesQ1 2025 Earnings ReportConference Call Transcript & Audio Quarterly Report (10-Q) Press Release (8-K)INO Upcoming EarningsInovio Pharmaceuticals' Q2 2025 earnings is scheduled for Tuesday, August 12, 2025, with a conference call scheduled at 4:30 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Q2 2025 Earnings ReportPowered by Get Inovio Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Inovio Pharmaceuticals and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataINO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.INO Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Inovio Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.75-$0.75-$0.75Q2 20251-$0.69-$0.69-$0.69Q3 20251-$0.57-$0.57-$0.57Q4 20251-$0.49-$0.49-$0.49 FY 2025 4 -$2.50 -$2.50 -$2.50 Q1 20261-$0.44-$0.44-$0.44Q2 20261-$0.39-$0.39-$0.39Q3 20261-$0.35-$0.35-$0.35Q4 20261-$0.31-$0.31-$0.31 Inovio Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/12/2025(Estimated)--$0.65-----5/13/2025Q1 2025-$0.74-$0.51+$0.23-$0.51$0.01M$0.07M3/18/2025Q4 2024-$0.87-$0.69+$0.18-$0.60$0.03M$0.12M8/8/2024Q2 2024-$1.10-$1.19 -$0.09-$1.19$0.10M$0.10M5/13/2024Q1 2024-$1.08-$1.31 -$0.23-$1.31$0.23M-11/9/2023Q3 2023-$18.72-$12.96+$5.76-$0.05$0.18M$0.39M Inovio Pharmaceuticals Earnings - Frequently Asked Questions When is Inovio Pharmaceuticals' earnings date? Inovio Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on INO's earnings history. Did Inovio Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Inovio Pharmaceuticals (NASDAQ:INO) reported ($0.51) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.74) by $0.23. Learn more on analysts' earnings estimate vs. INO's actual earnings. How can I listen to Inovio Pharmaceuticals' earnings conference call? The conference call for Inovio Pharmaceuticals' latest earnings report can be listened to online. Listen to Conference Call How can I read Inovio Pharmaceuticals' conference call transcript? The conference call transcript for Inovio Pharmaceuticals' latest earnings report can be read online. Read Transcript How much revenue does Inovio Pharmaceuticals generate each year? Inovio Pharmaceuticals (NASDAQ:INO) has a recorded annual revenue of $220,000.00. How much profit does Inovio Pharmaceuticals generate each year? Inovio Pharmaceuticals (NASDAQ:INO) has a recorded net income of -$107.25 million. INO has generated -$3.19 earnings per share over the last four quarters. What is Inovio Pharmaceuticals' EPS forecast for next year? Inovio Pharmaceuticals' earnings are expected to grow from ($4.23) per share to ($2.85) per share in the next year. More Earnings Resources from MarketBeat Related Companies MRNA Earnings CVRX Earnings SKIN Earnings MGRM Earnings SGHT Earnings INGN Earnings PROF Earnings KRMD Earnings TLSI Earnings ELMD Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles CrowdStrike Faces Valuation Test Before Key Earnings ReportPost-Earnings, How Does D-Wave Stack Up Against Quantum Rivals?Why SoundHound AI's Earnings Show the Stock Can Move HigherAirbnb Beats Earnings, But the Growth Story Is Losing AltitudeDutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?Constellation Energy’s Earnings Beat Signals a New Era This page (NASDAQ:INO) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredWhy Elon put $51 million into thisChris Rowe has made legendary calls—Tesla at $13, Nvidia at $40, Bitcoin under $1,000, Amazon at 12 cents. Now...True Market Insiders | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | SponsoredTop Picks for Trump’s Pro-Crypto America27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredSilver Demand Is Exploding—and Supply Can’t Keep UpElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inovio Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inovio Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access